Clinical Trials
3 trialsNCT06595563 2026-05-07
ZEPHIR-02
Jules Bordet Institute
Phase 2 Recruiting
NCT03417544 2026-04-27
Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT06551116 2026-04-07
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine
Recruiting